Prooxidant mechanisms in iron overload cardiomyopathy

BioMed Research International
Ching-Feng Cheng, Wei-Shiung Lian

Abstract

Iron overload cardiomyopathy (IOC), defined as the presence of systolic or diastolic cardiac dysfunction secondary to increased deposition of iron, is emerging as an important cause of heart failure due to the increased incidence of this disorder seen in thalassemic patients and in patients of primary hemochromatosis. At present, although palliative treatment by regular iron chelation was recommended; whereas IOC is still the major cause for mortality in patient with chronic heart failure induced by iron-overloading. Because iron is a prooxidant and the associated mechanism seen in iron-overload heart is still unclear; therefore, we intend to delineate the multiple signaling pathways involved in IOC. These pathways may include organelles such as calcium channels, mitochondria; paracrine effects from both macrophages and fibroblast, and novel mediators such as thromboxane A2 and adiponectin; with increased oxidative stress and inflammation found commonly in these signaling pathways. With further understanding on these complex and inter-related molecular mechanisms, we can propose potential therapeutic strategies to ameliorate the cardiac toxicity induced by iron-overloading.

References

Jul 11, 1992·Nucleic Acids Research·H U EnrightR P Hebbel
Sep 1, 1988·The Journal of Clinical Investigation·I SchraufstätterC G Cochrane
Oct 1, 1983·Cell·L C SkowS E Lewis
Apr 6, 1995·The New England Journal of Medicine·N F OlivieriG Koren
Aug 1, 1994·Archives of Pediatrics & Adolescent Medicine·J W HouH C Lue
Feb 1, 1994·Cardiovascular Drugs and Therapy·P Liu, N Olivieri
Sep 1, 1993·Circulation·D T KremastinosP K Toutouzas
Jan 21, 1997·Proceedings of the National Academy of Sciences of the United States of America·F M Yakes, B Van Houten
Jul 1, 1997·British Journal of Haematology·I Roberts
Jul 21, 1998·Annals of the New York Academy of Sciences·C HershkoI Cabantchik
Nov 7, 2002·Free Radical Biology & Medicine·G J QuinlanJ M C Gutteridge
Mar 6, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Masashi OhtsukaIssei Komuro
Apr 12, 2005·Annual Review of Pharmacology and Toxicology·James K Liao, Ulrich Laufs
Mar 31, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Elisabeth DeindlWolfgang-Michael Franz
Apr 11, 2006·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Gavin Y OuditPeter H Backx
Mar 6, 2007·Laboratory Investigation; a Journal of Technical Methods and Pathology·Longhu LiHisayoshi Fujiwara
Aug 3, 2007·American Journal of Physiology. Cell Physiology·Maya ShvartsmanZ Ioav Cabantchik
Oct 31, 2007·American Journal of Hematology·John B Porter
Dec 8, 2007·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·Olusegun A MojiminiyiNabila A Abdella
Dec 20, 2008·The Journal of Biological Chemistry·Xueshan GaoJohn W Eaton
Apr 23, 2010·The Biochemical Journal·Maya ShvartsmanZ Ioav Cabantchik
May 11, 2010·Free Radical Biology & Medicine·Xueshan GaoJohn W Eaton

❮ Previous
Next ❯

Citations

Feb 3, 2015·European Journal of Heart Failure·Theresa McDonagh, Iain C Macdougall
Aug 21, 2015·European Journal of Pharmacology·Suwakon WongjaikamNipon Chattipakorn
Apr 17, 2015·Oxidative Medicine and Cellular Longevity·Elena GammellaGaetano Cairo
Jan 25, 2017·Journal of the American Heart Association·Jason S ShapiroHossein Ardehali
Oct 26, 2018·The British Journal of Radiology·Jonathan Kim MohajerGiuseppe Schettino
Apr 20, 2019·Postgraduate Medicine·Amal PaulSunil K Nadar
May 6, 2017·IUBMB Life·Ana C MartinsRaffaella Gozzelino
Nov 11, 2019·British Journal of Pharmacology·Helbert Gabriel FidelisLeonardo Dos Santos
Dec 12, 2018·Journal of Cellular Physiology·Homa NomaniAmir Hooshang Mohammadpour
Dec 4, 2019·Clinica Chimica Acta; International Journal of Clinical Chemistry·Leilismara SousaLeandro A Barbosa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.